Actively Recruiting
Telehealth Follow-Up by Pharmacists and Intensivists to Support Recovery from Post Intensive Care Syndrome in Adults Aged 18 to 89
Led by Malcom Randall VA Medical Center · Updated on 2025-09-23
24
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether a collaborative telehealth follow-up by pharmacists and intensivists after discharge from the intensive care unit ICU is feasible for patients who have survived a critical illness. This pilot randomized controlled trial focuses on patients with Post Intensive Care Syndrome PICS who required significant ICU care, such as mechanical ventilation or extended ICU stays. The study aims to improve recovery by assessing post-ICU symptoms and recommending interventions. Participants will be randomly assigned to one of two groups one group will receive telehealth follow-up appointments with clinical pharmacists supported by intensivists at about one and three months after hospital discharge, while the other group will receive standard post-ICU care. These telehealth visits will be 30 to 60 minutes long and conducted via telephone or video, focusing on evaluating PICS symptoms and planning care improvements. During the study, participant progress will be monitored through these telehealth sessions, as well as assessments of quality of life at six months using a short survey. Researchers will also track hospital or ICU readmissions, emergency department visits, and mortality up to seven months after enrollment. The total follow-up period lasts seven months to ensure thorough observation of recovery and health outcomes.
CONDITIONS
Brief Title
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome
Research Team
A
Andrew J Franck, Pharm.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here